Works matching AU Leis, Jose F.

Results: 55
    1

    Clonal dynamics of Richter transformation in chronic lymphocytic leukemia.

    Published in:
    Hematological Oncology, 2024, v. 42, n. 4, p. 1, doi. 10.1002/hon.3282
    By:
    • Wang, Hanyin;
    • Tian, Shulan;
    • Secreto, Charla R.;
    • Sinha, Sutapa;
    • Shi, Min;
    • Call, Timothy;
    • Wang, Yucai;
    • Parikh, Sameer A.;
    • Kenderian, Saad S.;
    • He, Rong;
    • Leis, Jose F.;
    • VanDyke, Daniel L.;
    • Klee, Eric W.;
    • Slager, Susan L.;
    • Braggio, Esteban;
    • Yan, Huihuang;
    • Ding, Wei
    Publication type:
    Article
    2

    Differential transcriptomic profiling in ibrutinib‐naïve versus ibrutinib‐resistant Richter syndrome.

    Published in:
    Hematological Oncology, 2022, v. 40, n. 2, p. 302, doi. 10.1002/hon.2950
    By:
    • Wang, Hanyin;
    • Tian, Shulan;
    • Zhao, Qing;
    • Blumenschein, Wendy;
    • Yearley, Jennifer H.;
    • Secreto, Charla R.;
    • Sinha, Sutapa;
    • Call, Timothy G.;
    • Wang, Yucai;
    • Parikh, Sameer A.;
    • Kenderian, Saad S.;
    • He, Rong;
    • Leis, Jose F.;
    • Shi, Min;
    • Van Dyke, Daniel L.;
    • Kay, Neil E.;
    • Slager, Susan L.;
    • Braggio, Esteban;
    • Yan, Huihuang;
    • Ding, Wei
    Publication type:
    Article
    3
    4
    5
    6
    7
    8

    Combined ibrutinib and venetoclax for treatment of patients with ibrutinib‐resistant or double‐refractory chronic lymphocytic leukaemia.

    Published in:
    British Journal of Haematology, 2022, v. 199, n. 2, p. 239, doi. 10.1111/bjh.18357
    By:
    • Hampel, Paul J.;
    • Rabe, Kari G.;
    • Call, Timothy G.;
    • Ding, Wei;
    • Leis, Jose F.;
    • Kenderian, Saad S.;
    • Muchtar, Eli;
    • Wang, Yucai;
    • Koehler, Amber B.;
    • Parrondo, Ricardo;
    • Schwager, Susan M.;
    • Shi, Min;
    • Braggio, Esteban;
    • Slager, Susan L.;
    • Kay, Neil E.;
    • Parikh, Sameer A.
    Publication type:
    Article
    9

    Response to COVID-19 Vaccination Post-CAR T Therapy in Patients With Non-Hodgkin Lymphoma and Multiple Myeloma.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 6, p. 456, doi. 10.1016/j.clml.2023.03.002
    By:
    • Wiedmeier-Nutor, Julia E.;
    • Iqbal, Madiha;
    • Rosenthal, Allison C.;
    • Bezerra, Evandro D.;
    • Garcia-Robledo, Juan Esteban;
    • Bansal, Radhika;
    • Johnston, Patrick B.;
    • Hathcock, Matthew;
    • Larsen, Jeremy T.;
    • Leif Bergsagel, P.;
    • Wang, Yucai;
    • Reeder, Craig B.;
    • Leis, Jose F.;
    • Fonseca, Rafael;
    • Palmer, Jeanne M.;
    • Gysbers, Brianna J.;
    • Mwangi, Raphael;
    • Warsame, Rahma M.;
    • Kourelis, Taxiarchis;
    • Hayman, Suzanne R.
    Publication type:
    Article
    10

    A Novel Combination of the mTORC1 Inhibitor Everolimus and the Immunomodulatory Drug Lenalidomide Produces Durable Responses in Patients With Heavily Pretreated Relapsed Lymphoma.

    Published in:
    2018
    By:
    • Padrnos, Leslie;
    • Ernst, Brenda;
    • Dueck, Amylou C.;
    • Kosiorek, Heidi E.;
    • Ginos, Brenda F.;
    • Toro, Angela;
    • Johnston, Patrick B.;
    • Habermann, Thomas M.;
    • Leis, Jose F.;
    • Mikhael, Joseph R.;
    • Nowakowski, Grzegorz S.;
    • Colgan, Joseph;
    • Porrata, Luis;
    • Ansell, Stephen M.;
    • Witzig, Thomas E.;
    • Reeder, Craig
    Publication type:
    journal article
    11
    12
    13
    14
    15

    Atrial fibrillation in patients with chronic lymphocytic leukemia (CLL) treated with ibrutinib: risk prediction, management, and clinical outcomes.

    Published in:
    Annals of Hematology, 2021, v. 100, n. 1, p. 143, doi. 10.1007/s00277-020-04094-3
    By:
    • Archibald, William J.;
    • Rabe, Kari G.;
    • Kabat, Brian F.;
    • Herrmann, Joerg;
    • Ding, Wei;
    • Kay, Neil E.;
    • Kenderian, Saad S.;
    • Muchtar, Eli;
    • Leis, Jose F.;
    • Wang, Yucai;
    • Chanan-Khan, Asher A.;
    • Schwager, Susan M.;
    • Koehler, Amber B.;
    • Fonder, Amie L.;
    • Slager, Susan L.;
    • Shanafelt, Tait D.;
    • Call, Timothy G.;
    • Parikh, Sameer A.
    Publication type:
    Article
    16
    17

    The impact of dose modification and temporary interruption of ibrutinib on outcomes of chronic lymphocytic leukemia patients in routine clinical practice.

    Published in:
    Cancer Medicine, 2020, v. 9, n. 10, p. 3390, doi. 10.1002/cam4.2998
    By:
    • Parikh, Sameer A.;
    • Achenbach, Sara J.;
    • Call, Timothy G.;
    • Rabe, Kari G.;
    • Ding, Wei;
    • Leis, Jose F.;
    • Kenderian, Saad S.;
    • Chanan‐Khan, Asher A.;
    • Koehler, Amber B.;
    • Schwager, Susan M.;
    • Muchtar, Eli;
    • Fonder, Amie L.;
    • McCullough, Kristen B.;
    • Nedved, Adrienne N.;
    • Smith, Matthew D.;
    • Slager, Susan L.;
    • Kay, Neil E.;
    • Finnes, Heidi D.;
    • Shanafelt, Tait D.
    Publication type:
    Article
    18

    Early post-transplantation factors predict survival outcomes in patients undergoing allogeneic hematopoietic cell transplantation for myelofibrosis.

    Published in:
    Blood Cancer Journal, 2020, v. 10, n. 3, p. 1, doi. 10.1038/s41408-020-0302-9
    By:
    • Jain, Tania;
    • Kunze, Katie L.;
    • Mountjoy, Luke;
    • Partain, Daniel K.;
    • Kosiorek, Heidi;
    • Khera, Nandita;
    • Hogan, William J.;
    • Roy, Vivek;
    • Slack, James L.;
    • Noel, Pierre;
    • Fauble, Veena D. S.;
    • Leis, Jose F.;
    • Sproat, Lisa;
    • Tefferi, Ayalew;
    • Patnaik, Mrinal M.;
    • Mesa, Ruben A.;
    • Palmer, Jeanne
    Publication type:
    Article
    19

    Autoimmune cytopenias in patients with chronic lymphocytic leukaemia treated with ibrutinib in routine clinical practice at an academic medical centre.

    Published in:
    British Journal of Haematology, 2018, v. 183, n. 3, p. 421, doi. 10.1111/bjh.15545
    By:
    • Hampel, Paul J.;
    • Larson, Melissa C.;
    • Kabat, Brian;
    • Call, Timothy G.;
    • Ding, Wei;
    • Kenderian, Saad S.;
    • Bowen, Deborah;
    • Boysen, Justin;
    • Schwager, Susan M.;
    • Leis, Jose F.;
    • Chanan‐Khan, Asher A.;
    • Muchtar, Eli;
    • Hanson, Curtis A.;
    • Slager, Susan L.;
    • Kay, Neil E.;
    • Chaffee, Kari G.;
    • Shanafelt, Tait D.;
    • Parikh, Sameer A.
    Publication type:
    Article
    20
    21
    22
    23
    24

    Common variants within 6p21.31 locus are associated with chronic lymphocytic leukaemia and, potentially, other non- Hodgkin lymphoma subtypes.

    Published in:
    British Journal of Haematology, 2012, v. 159, n. 5, p. 572, doi. 10.1111/bjh.12070
    By:
    • Slager, Susan L.;
    • Camp, Nicola J.;
    • Conde, Lucia;
    • Shanafelt, Tait D.;
    • Achenbach, Sara J.;
    • Rabe, Kari G.;
    • Kay, Neil E.;
    • Novak, Anne J.;
    • Call, Timothy G.;
    • Bracci, Paige M.;
    • Sille, Fenna M. C.;
    • Sanchez, Sylvia;
    • Akers, Nicholas K.;
    • Cunningham, Julie M.;
    • Serie, Daniel J.;
    • McDonnell, Shannon K.;
    • Leis, Jose F.;
    • Wang, Alice H.;
    • Weinberg, J. Brice;
    • Glenn, Martha
    Publication type:
    Article
    25

    Common occurrence of monoclonal B-cell lymphocytosis among members of high-risk CLL families.

    Published in:
    British Journal of Haematology, 2010, v. 151, n. 2, p. 152, doi. 10.1111/j.1365-2141.2010.08339.x
    By:
    • Goldin, Lynn R.;
    • Lanasa, Mark C.;
    • Slager, Susan L.;
    • Cerhan, James R.;
    • Vachon, Celine M.;
    • Strom, Sara S.;
    • Camp, Nicola J.;
    • Spector, Logan G.;
    • Leis, Jose F.;
    • Morrison, Vicki A.;
    • Glenn, Martha;
    • Rabe, Kari G.;
    • Achenbach, Sara J.;
    • Algood, Sallie D.;
    • Abbasi, Fatima;
    • Fontaine, Laura;
    • Yau, Michelle;
    • Rassenti, Laura Z.;
    • Kay, Neil E.;
    • Call, Timothy G.
    Publication type:
    Article
    26
    27

    Clinical outcomes in patients with chronic lymphocytic leukemia with disease progression on ibrutinib.

    Published in:
    Blood Cancer Journal, 2022, v. 12, n. 9, p. 1, doi. 10.1038/s41408-022-00721-6
    By:
    • Hampel, Paul J.;
    • Rabe, Kari G.;
    • Call, Timothy G.;
    • Ding, Wei;
    • Leis, Jose F.;
    • Chanan-Khan, Asher A.;
    • Kenderian, Saad S.;
    • Muchtar, Eli;
    • Wang, Yucai;
    • Ailawadhi, Sikander;
    • Koehler, Amber B.;
    • Parrondo, Ricardo;
    • Schwager, Susan M.;
    • Sher, Taimur;
    • Hanson, Curtis A.;
    • Shi, Min;
    • Van Dyke, Daniel L.;
    • Braggio, Esteban;
    • Slager, Susan L.;
    • Kay, Neil E.
    Publication type:
    Article
    28

    Chronic lymphocytic leukemia (CLL) with Reed–Sternberg-like cells vs Classic Hodgkin lymphoma transformation of CLL: does this distinction matter?

    Published in:
    Blood Cancer Journal, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41408-022-00616-6
    By:
    • King, Rebecca L.;
    • Gupta, Alia;
    • Kurtin, Paul J.;
    • Ding, Wei;
    • Call, Timothy G.;
    • Rabe, Kari G.;
    • Kenderian, Saad S.;
    • Leis, Jose F.;
    • Wang, Yucai;
    • Schwager, Susan M.;
    • Slager, Susan L.;
    • Kay, Neil. E.;
    • Koehler, Amber;
    • Ansell, Stephen M.;
    • Inwards, David J.;
    • Habermann, Thomas M.;
    • Shi, Min;
    • Hanson, Curtis A.;
    • Howard, Matthew T.;
    • Parikh, Sameer A.
    Publication type:
    Article
    29
    30

    Distinct immune signatures in chronic lymphocytic leukemia and Richter syndrome.

    Published in:
    Blood Cancer Journal, 2021, v. 11, n. 5, p. 1, doi. 10.1038/s41408-021-00477-5
    By:
    • Wang, Yucai;
    • Sinha, Sutapa;
    • Wellik, Linda E.;
    • Secreto, Charla R.;
    • Rech, Karen L.;
    • Call, Timothy G.;
    • Parikh, Sameer A.;
    • Kenderian, Saad S.;
    • Muchtar, Eli;
    • Hayman, Suzanne R.;
    • Koehler, Amber B.;
    • Van Dyke, Daniel L.;
    • Leis, Jose F.;
    • Slager, Susan L.;
    • Dong, Haidong;
    • Kay, Neil E.;
    • He, Rong;
    • Ding, Wei
    Publication type:
    Article
    31

    Venetoclax treatment of patients with relapsed T-cell prolymphocytic leukemia.

    Published in:
    2021
    By:
    • Hampel, Paul J.;
    • Parikh, Sameer A.;
    • Call, Timothy G.;
    • Shah, Mithun V.;
    • Bennani, N. Nora;
    • Al-Kali, Aref;
    • Rabe, Kari G.;
    • Wang, Yucai;
    • Muchtar, Eli;
    • Leis, Jose F.;
    • Kenderian, Saad S.;
    • Koehler, Amber B.;
    • Schwager, Susan M.;
    • Slager, Susan L.;
    • Kay, Neil E.;
    • Hanson, Curtis A.;
    • Van Dyke, Daniel L.;
    • Shi, Min;
    • Ding, Wei
    Publication type:
    Letter
    32

    DTRMWXHS‐12, a novel Bruton tyrosine kinase inhibitor, in combination with everolimus and pomalidomide in patients with relapsed/refractory lymphomas: An open‐label, multicenter, phase 1a/1b study.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 5, p. 739, doi. 10.1002/ajh.26888
    By:
    • Huntington, Scott F.;
    • Schuster, Stephen J.;
    • Ding, Wei;
    • Koehler, Amber B.;
    • Brander, Danielle M.;
    • Rosenthal, Allison C.;
    • Leis, Jose F.;
    • Tun, Han W.;
    • Moustafa, Muhamad Alhaj;
    • Iqbal, Madiha;
    • He, Wei;
    • Kearney, Albert S.;
    • McKinlay, Timothy P.;
    • Gui, Min;
    • Mato, Anthony R.
    Publication type:
    Article
    33
    34

    Humoral and cellular immune responses to recombinant herpes zoster vaccine in patients with chronic lymphocytic leukemia and monoclonal B cell lymphocytosis.

    Published in:
    American Journal of Hematology, 2022, v. 97, n. 1, p. 90, doi. 10.1002/ajh.26388
    By:
    • Muchtar, Eli;
    • Koehler, Amber B.;
    • Johnson, Michael J.;
    • Rabe, Kari G.;
    • Ding, Wei;
    • Call, Timothy G.;
    • Leis, Jose F.;
    • Kenderian, Saad S.;
    • Hayman, Suzanne R.;
    • Wang, Yucai;
    • Hampel, Paul J.;
    • Holets, Matthew A.;
    • Darby, Heather C.;
    • Slager, Susan L.;
    • Kay, Neil E.;
    • Miao, Congrong;
    • Canniff, Jennifer;
    • Whitaker, Jennifer A.;
    • Levin, Myron J.;
    • Schmid, D. Scott
    Publication type:
    Article
    35

    The prognostic significance of del6q23 in chronic lymphocytic leukemia.

    Published in:
    American Journal of Hematology, 2021, v. 96, n. 6, p. E203, doi. 10.1002/ajh.26168
    By:
    • Audil, Hadiyah Y.;
    • Hampel, Paul J.;
    • Van Dyke, Daniel L.;
    • Achenbach, Sara J.;
    • Rabe, Kari G.;
    • Smoley, Stephanie A.;
    • Call, Timothy G.;
    • Ding, Wei;
    • Shi, Min;
    • Hanson, Curtis A.;
    • Wang, Yucai;
    • Muchtar, Eli;
    • Koehler, Amber B.;
    • Schwager, Susan M.;
    • Leis, Jose F.;
    • Braggio, Esteban;
    • Slager, Susan L.;
    • Kay, Neil E.;
    • Kenderian, Saad S.;
    • Parikh, Sameer A.
    Publication type:
    Article
    36

    Tumor mutational load predicts time to first treatment in chronic lymphocytic leukemia (CLL) and monoclonal B‐cell lymphocytosis beyond the CLL international prognostic index.

    Published in:
    American Journal of Hematology, 2020, v. 95, n. 8, p. 906, doi. 10.1002/ajh.25831
    By:
    • Kleinstern, Geffen;
    • O'Brien, Daniel R.;
    • Li, Xing;
    • Tian, Shulan;
    • Kabat, Brian F.;
    • Rabe, Kari G.;
    • Norman, Aaron D.;
    • Yan, Huihuang;
    • Vachon, Celine M.;
    • Boddicker, Nicholas J.;
    • Call, Timothy G.;
    • Parikh, Sameer A.;
    • Bruins, Laura;
    • Bonolo de Campos, Cecilia;
    • Leis, Jose F.;
    • Shanafelt, Tait D.;
    • Ding, Wei;
    • Cerhan, James R.;
    • Kay, Neil E.;
    • Slager, Susan L.
    Publication type:
    Article
    37

    Addition of venetoclax at time of progression in ibrutinib‐treated patients with chronic lymphocytic leukemia: Combination therapy to prevent ibrutinib flare.

    Published in:
    American Journal of Hematology, 2020, v. 95, n. 3, p. E57, doi. 10.1002/ajh.25690
    By:
    • Hampel, Paul J.;
    • Call, Timothy G.;
    • Ding, Wei;
    • Muchtar, Eli;
    • Kenderian, Saad S.;
    • Wang, Yucai;
    • Leis, Jose F.;
    • Witzig, Thomas E.;
    • Koehler, Amber B.;
    • Fonder, Amie L.;
    • Schwager, Susan M.;
    • Rabe, Kari G.;
    • Van Dyke, Daniel L.;
    • Braggio, Esteban;
    • Slager, Susan L.;
    • Kay, Neil E.;
    • Parikh, Sameer A.
    Publication type:
    Article
    38

    IGH translocations in chronic lymphocytic leukemia: Clinicopathologic features and clinical outcomes.

    Published in:
    American Journal of Hematology, 2019, v. 94, n. 3, p. 338, doi. 10.1002/ajh.25385
    By:
    • Fang, Hong;
    • Reichard, Kaaren K.;
    • Rabe, Kari G.;
    • Hanson, Curtis A.;
    • Call, Timothy G.;
    • Ding, Wei;
    • Kenderian, Saad S.;
    • Muchtar, Eli;
    • Schwager, Susan M.;
    • Leis, Jose F.;
    • Chanan‐Khan, Asher A.;
    • Slager, Susan L.;
    • Braggio, Esteban;
    • Smoley, Stephanie A.;
    • Kay, Neil E.;
    • Shanafelt, Tait D.;
    • Van Dyke, Daniel L.;
    • Parikh, Sameer A.
    Publication type:
    Article
    39

    Liver dysfunction in chronic lymphocytic leukemia: Prevalence, outcomes, and pathological findings.

    Published in:
    American Journal of Hematology, 2017, v. 92, n. 12, p. 1362, doi. 10.1002/ajh.24915
    By:
    • Hampel, Paul J.;
    • Chaffee, Kari G.;
    • King, Rebecca L.;
    • Simonetto, Douglas;
    • Larson, Melissa C.;
    • Achenbach, Sara;
    • Call, Timothy G.;
    • Ding, Wei;
    • Kenderian, Saad S.;
    • Leis, Jose F.;
    • Chanan-Khan, Asher A.;
    • Bowen, Deborah A.;
    • Conte, Michael J.;
    • Schwager, Susan M.;
    • Hanson, Curtis A.;
    • Slager, Susan L.;
    • Kay, Neil E.;
    • Shanafelt, Tait D.;
    • Parikh, Sameer A.
    Publication type:
    Article
    40

    Akt inhibitor MK-2206 in combination with bendamustine and rituximab in relapsed or refractory chronic lymphocytic leukemia: Results from the N1087 alliance study.

    Published in:
    American Journal of Hematology, 2017, v. 92, n. 8, p. 759, doi. 10.1002/ajh.24762
    By:
    • Larsen, Jeremy T.;
    • Shanafelt, Tait D.;
    • Leis, Jose F.;
    • LaPlant, Betsy;
    • Call, Tim;
    • Pettinger, Adam;
    • Hanson, Curtis;
    • Erlichman, Charles;
    • Habermann, Thomas Matthew;
    • Reeder, Craig;
    • Nikcevich, Daniel;
    • Bowen, Deborah;
    • Conte, Michael;
    • Boysen, Justin;
    • Secreto, Charla;
    • Lesnick, Connie;
    • Tschumper, Renee;
    • Jelinek, Diane;
    • Kay, Neil E.;
    • Ding, Wei
    Publication type:
    Article
    41

    A phase 2 study of lenalidomide, rituximab, cyclophosphamide, and dexamethasone (LR-CD) for untreated low-grade non-Hodgkin lymphoma requiring therapy.

    Published in:
    American Journal of Hematology, 2017, v. 92, n. 5, p. 467, doi. 10.1002/ajh.24693
    By:
    • Rosenthal, Allison;
    • Dueck, Amylou C.;
    • Ansell, Stephen;
    • Gano, Katherine;
    • Conley, Christopher;
    • Nowakowski, Grzegorz S.;
    • Camoriano, John;
    • Leis, Jose F.;
    • Mikhael, Joseph R.;
    • Keith Stewart, A.;
    • Inwards, David;
    • Dingli, David;
    • Kumar, Shaji;
    • Noel, Pierre;
    • Gertz, Morie;
    • Porrata, Luis;
    • Russell, Stephen;
    • Colgan, Joseph;
    • Fonseca, Rafael;
    • Habermann, Thomas M.
    Publication type:
    Article
    42
    43
    44
    45

    Incidence and risk of tumor lysis syndrome in patients with relapsed chronic lymphocytic leukemia (CLL) treated with venetoclax in routine clinical practice.

    Published in:
    Leukemia & Lymphoma, 2020, v. 61, n. 10, p. 2383, doi. 10.1080/10428194.2020.1768384
    By:
    • Koehler, Amber B.;
    • Leung, Nelson;
    • Call, Timothy G.;
    • Rabe, Kari G.;
    • Achenbach, Sara J.;
    • Ding, Wei;
    • Kenderian, Saad S.;
    • Leis, Jose F.;
    • Wang, Yucai;
    • Muchtar, Eli;
    • Hayman, Suzanne R.;
    • Hampel, Paul J.;
    • Finnes, Heidi D.;
    • Schwager, Susan M.;
    • Slager, Susan L.;
    • Kay, Neil E.;
    • Parikh, Sameer A.
    Publication type:
    Article
    46
    47

    Rapid disease progression following discontinuation of ibrutinib in patients with chronic lymphocytic leukemia treated in routine clinical practice.

    Published in:
    Leukemia & Lymphoma, 2019, v. 60, n. 11, p. 2712, doi. 10.1080/10428194.2019.1602268
    By:
    • Hampel, Paul J.;
    • Ding, Wei;
    • Call, Timothy G.;
    • Rabe, Kari G.;
    • Kenderian, Saad S.;
    • Witzig, Thomas E.;
    • Muchtar, Eli;
    • Leis, Jose F.;
    • Chanan-Khan, Asher A.;
    • Koehler, Amber B.;
    • Fonder, Amie L.;
    • Schwager, Susan M.;
    • Slager, Susan L.;
    • Shanafelt, Tait D.;
    • Kay, Neil E.;
    • Parikh, Sameer A.
    Publication type:
    Article
    48
    49
    50

    A phase 2 study of rituximab, cyclophosphamide, bortezomib and dexamethasone (R-CyBorD) in relapsed low grade and mantle cell lymphoma.

    Published in:
    Leukemia & Lymphoma, 2018, v. 59, n. 9, p. 2128, doi. 10.1080/10428194.2017.1416368
    By:
    • Sonbol, Mohamad Bassam;
    • Hilal, Talal;
    • Rosenthal, Allison C.;
    • Leis, Jose F.;
    • Northfelt, Donald W.;
    • Bergsagel, Peter Leif;
    • Reeder, Craig B.;
    • Dueck, Amylou C.;
    • Kosiorek, Heidi E.;
    • Ginos, Brenda F.;
    • Conley, Christopher R.;
    • Gano, Katherine M.;
    • Nichols, Craig S.;
    • Johnston, Patrick B.;
    • Habermann, Thomas M.;
    • Inwards, David J.;
    • Witzig, Thomas E.;
    • Ansell, Stephen M.
    Publication type:
    Article